Role of mTOR Inhibition in Kidney Cancer

0 Views
administrator
administrator
07/10/23

James J. Hsieh, MD, PhD; Thomas Hutson, DO, PharmD, FACP; and Martin H. Voss, MD, review the clinical rationale for mTOR inhibition in the treatment of renal cell carcinoma and its current role in the first and second line.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next